About
Ophthalmology Therapies
Areas of Focus
Categories
Biologics & BiopharmaceuticalBiotech
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
105
By Phase
PHASE1/PHASE2: 2
By Status
RECRUITING: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06087458Lead Sponsor
Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration
PHASE1/PHASE2Recruiting
60 participants
Started: Jun 21, 2023 · Completed: Mar 31, 2028
NCT05380492Lead Sponsor
Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration
PHASE1/PHASE2Active, not recruiting
45 participants
Started: Nov 17, 2022 · Completed: Nov 30, 2025
Funding History (1)
D
Jan 13, 2023
Locations (1)
Headquarters
South SF, CA, United States
Map
Loading map...